Ginkgo Bioworks cell programming platform for custom enzyme and organism engineering.
Ginkgo Bioworks operates a foundry platform that designs and optimizes enzymes and microbial strains for customers across pharma, industrial, and consumer markets. The platform competes with specialized protein-engineering vendors on custom enzyme discovery and process biology partnerships.
Enterprise buyers engage Ginkgo for end-to-end biological design programs that can substitute or complement dedicated biocatalysis service providers when broader strain and pathway engineering is required.
Codexis
Pharma Biocatalysis
codexis.com
Prolific Machines
Photomolecular Platform
prolific-machines.com
Strateos
Strateos Remote Lab Platform
strateos.com
| Attribute | Cell Programming Platform | Pharma Biocatalysis | Photomolecular Platform | Strateos Remote Lab Platform | |
|---|---|---|---|---|---|
| Provider | | | | | |
| Founded | 2008 | 2002 | 2020 | 2019 | |
| Sells To | Enterprise | Enterprise | Enterprise | Enterprise | |
| Pricing Model | Recurring, Software | Recurring, Software | Recurring | Recurring, Software, Usage-based | |
| Ownership | Public | Public | Private equity-backed, Venture-backed | Venture-backed |
Provider
Founded 2008
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public
Provider
Founded 2002
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public
Provider
Founded 2020
Sells To Enterprise
Pricing Model Recurring
Ownership Private equity-backed, Venture-backed
Provider
Founded 2019
Sells To Enterprise
Pricing Model Recurring, Software, Usage-based
Ownership Venture-backed
Bespoke enzymes engineered for molecular biology and diagnostic applications.
Thermo Fisher catalog and specialty enzymes for molecular biology workflows.
Novozymes industrial enzyme products for biocatalysis and process chemistry.
Gene Circuit Therapeutics is the primary commercial offering marketed by Senti Biosciences to its core customer segments.
Genomic Medicine Platform is the primary commercial offering marketed by Range Biotechnologies to its core customer segments.
KBI Biopharma CHO cell-line development platform powered by Selexis for recombinant protein production.
LonzaLonza CHO gene-expression platform for developing and manufacturing recombinant protein biologics.
Automated cloud laboratory that runs a broad menu of biology and chemistry experiments on behalf of researchers.
AI-native platform that designs, runs, and improves plate-based scientific experiments autonomously.
Bespoke enzymes engineered for molecular biology and diagnostic applications.
Thermo Fisher catalog and specialty enzymes for molecular biology workflows.
Novozymes industrial enzyme products for biocatalysis and process chemistry.
Gene Circuit Therapeutics is the primary commercial offering marketed by Senti Biosciences to its core customer segments.
Genomic Medicine Platform is the primary commercial offering marketed by Range Biotechnologies to its core customer segments.
KBI Biopharma CHO cell-line development platform powered by Selexis for recombinant protein production.
Catalent mammalian cell-line development platform for high-titer stable CHO and HEK production lines.
Lonza CHO gene-expression platform for developing and manufacturing recombinant protein biologics.
LonzaAutomated cloud laboratory that runs a broad menu of biology and chemistry experiments on behalf of researchers.
AI-native platform that designs, runs, and improves plate-based scientific experiments autonomously.